HealthTree University: Know Your Therapy - Hypomethylating Agents (Azacitidine and Decitabine)
Hypomethylating agents are an effective medication for treating acute myeloid leukemia (AML), but they can cause some side effects. Despite the side effects, these drugs are still considered an important part of AML treatment, as they can slow the growth of cancer cells and improve patients' overall survival rates. Learn more about the effectiveness and potential side effects of hypomethylating agents for AML from the experts below! You can watch the full course on HealthTree University for free. Create a HealthTree University account to track your progress, take notes, and bookmark favorite lessons.
18.07 What are the common side effects of hypomethylating agents?
18.09 Can hypomethylating agents cure AML?
18.1 What research is being done to make hypomethylating agents more effective?
We’d like to thank our faculty who donated their time in creating these videos, including:
- Elias Jabbour, MD
We have over 100 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of AML from some of the top AML doctors in the world!
- AML Basics Part 1
- AML Basics Part 2
- AML Basics Part 3
- AML Genetics
- Building Your Healthcare Team
- AML Drug Classes
- Starting AML Treatment
- Allogeneic Stem Cell Transplant for AML
- Myelodysplastic Syndrome (MDS)
- Relapsed and Refractory AML
- AML Clinical Trials
- AML in Women
- An Introduction to Childhood AML
- AML Financial Toxicity
- Geriatric Care and AML
- Palliative Care
about the author
Clark Ahlstrom is the video team manager for HealthTree University and oversees video production of new HealthTree University videos. He started working at the foundation together with Jenny Ahlstrom, his mother, after her myeloma diagnosis.